Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH Logo National Institutes of Health

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued NOFO Number Activity Code Posting Date Expiration Date Opportunity Type
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) ✔ RFA-TR-23-016 R21 07/05/2023 06/02/2025 NA
Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Cli... ✔ NOT-TR-23-015 05/03/2023 Notice of Intent to Publish
Notice of Termination of PAR-22-058 Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Invest... ✔ NOT-TR-23-014 04/19/2023 Notice of Information
Notice of Termination of RFA-TR-22-013 Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) ✔ NOT-TR-23-013 04/19/2023 Notice of Information
STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limit... ✘ PAR-23-144 UC2 04/19/2023 09/18/2025 NA
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed ✔ PAR-23-268 UT1 04/18/2023 06/06/2025 NA
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed) ✔ PAR-23-267 U43/U44 04/18/2023 06/06/2025 NA
Notice of Termination of RFA-TR-22-011 HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Drugg... ✔ NOT-TR-23-012 04/17/2023 Notice of Information
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) ✔ PAR-23-159 R21 04/13/2023 10/17/2024 NA
Notice of Change in Eligibility for CTSA Program Funding Opportunities: PAR-21-336 (K12), PAR-21-339 (R25), PAR-21-338 (T32), and PAR-21-337 (T32) ✔ NOT-TR-22-035 UM1 10/07/2022 Notice of Change to Funding Opportunity
Showing Row 111 to 120 of 377

Last updated on April 19, 2024